What is the management of alcohol-induced hepatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Alcohol-Induced Hepatitis

Alcohol abstinence combined with aggressive nutritional support forms the foundation of treatment, with prednisolone 40 mg daily for 28 days reserved for severe disease (Maddrey discriminant function ≥32 or MELD >20) in patients without contraindications. 1, 2, 3

Initial Assessment and Risk Stratification

Severity scoring is mandatory to guide treatment decisions:

  • Calculate Maddrey discriminant function (MDF): MDF >32 indicates severe disease with 40-50% mortality within 90 days without treatment 1
  • Calculate MELD score: MELD >20 predicts high 90-day mortality 1, 2
  • Alternative severity markers: Glasgow alcoholic hepatitis score ≥9 or ABIC score category C also indicate severe disease 1, 3
  • Laboratory parameters are more reliable than clinical symptoms for predicting severity 1

Screen for infections immediately, regardless of fever presence:

  • Obtain blood, urine, and ascites cultures (if ascites present) before initiating any immunosuppressive therapy 1, 2
  • Infections are common due to impaired neutrophil function and dramatically worsen prognosis 1, 3

Universal Treatment Components (All Patients)

Alcohol Abstinence

Complete and permanent abstinence is non-negotiable:

  • There is no safe amount of alcohol consumption after alcoholic hepatitis 3
  • Consider pharmacologic support: naltrexone or acamprosate combined with counseling to reduce relapse risk 1, 3
  • Baclofen can also be used to achieve abstinence 1
  • Brief interventions are cost-effective and should be implemented in all patients 1

Aggressive Nutritional Support

Provide high-calorie, high-protein nutrition:

  • Target 30-40 kcal/kg/day and 1.2-1.5 g/kg/day protein 1, 2, 3
  • If oral intake is inadequate, use enteral feeding via feeding tube—parenteral nutrition alone is inadequate 1
  • Enteral nutrition improves survival regardless of steroid treatment 3, 4
  • Supplement with vitamins and minerals: vitamin A, thiamine, vitamin B12, folic acid, pyridoxine, vitamin D, and zinc 1
  • Consider more frequent smaller meals if three meals daily are insufficient 1

Treatment Based on Disease Severity

Severe Alcoholic Hepatitis (MDF ≥32 or MELD >20)

Prednisolone 40 mg daily for 28 days is first-line pharmacologic therapy:

  • Improves 28-day survival by reducing pro-inflammatory cytokines including TNF-α 3, 5
  • Follow with either abrupt discontinuation or 2-week taper 2
  • Assess response at day 7 using Lille model: Lille score <0.45 indicates good response (85% 6-month survival), while Lille score >0.45 indicates poor response (25% 6-month survival) 2, 3
  • Discontinue steroids immediately in non-responders as infections occur more frequently in this group 3

Absolute contraindications to corticosteroids:

  • Active gastrointestinal bleeding 3
  • Renal failure 3
  • Acute pancreatitis 3
  • Uncontrolled infection 3

Consider N-acetylcysteine as adjunctive therapy:

  • When added to corticosteroids, decreases hepatorenal syndrome, infection, and short-term mortality 6
  • Does not significantly affect 6-month mortality 6

Mild to Moderate Alcoholic Hepatitis (MDF <32)

Supportive care without corticosteroids:

  • Abstinence and nutritional support are sufficient 7, 8
  • Most patients improve significantly with these measures alone 8
  • Long-term outcome depends primarily on maintaining abstinence 8

Critical Management Considerations

Avoid Nephrotoxic Agents

Acute kidney injury represents early multi-organ failure:

  • Avoid diuretics in the acute phase 2, 3
  • Use caution with iodinated contrast agents for imaging—they increase acute kidney injury risk 1, 2

Monitor for Infections Continuously

Infections can develop after initial diagnosis and carry high mortality:

  • Particularly dangerous in steroid non-responders 3
  • Infections account for the majority of deaths in the weeks following steroid treatment 4
  • Maintain high index of suspicion even without fever 1

Hospitalization Criteria

Admit patients with:

  • Severe alcoholic hepatitis (MDF ≥32 or MELD >20) 1
  • Inadequate social or medical support 1
  • Need for supervised abstinence and nutritional restoration 1

Common Pitfalls to Avoid

  • Do not use pentoxifylline: Current evidence does not support its use outside clinical trials 5
  • Do not continue steroids beyond day 7 in non-responders: This increases infection risk without benefit 3
  • Do not rely on parenteral nutrition alone: Enteral feeding is superior 1
  • Do not overlook the majority of patients who have underlying cirrhosis at the time of alcoholic hepatitis diagnosis 1

Long-Term Prognosis

Even with optimal treatment, outcomes remain poor:

  • One-year mortality approaches 56% even with treatment 1
  • Return to drinking is a major contributor to long-term mortality 1
  • Steatosis is reversible with abstinence, but alcoholic hepatitis can persist and progress to cirrhosis even with abstinence 7
  • Liver transplantation may be considered in highly selected patients with severe complications, though this remains controversial 7, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Treatment for Alcoholic Hepatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Alcoholic Hepatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Alcoholic hepatitis: current trends in management.

Current opinion in gastroenterology, 2017

Research

Alcoholic hepatitis: current management.

Digestive diseases and sciences, 2014

Research

The treatment of alcoholic hepatitis.

Alcohol and alcoholism (Oxford, Oxfordshire), 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.